1. Home
  2. ARCT vs NDMO Comparison

ARCT vs NDMO Comparison

Compare ARCT & NDMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • NDMO
  • Stock Information
  • Founded
  • ARCT 2013
  • NDMO 2019
  • Country
  • ARCT United States
  • NDMO United States
  • Employees
  • ARCT N/A
  • NDMO N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • NDMO Trusts Except Educational Religious and Charitable
  • Sector
  • ARCT Health Care
  • NDMO Finance
  • Exchange
  • ARCT Nasdaq
  • NDMO Nasdaq
  • Market Cap
  • ARCT 298.3M
  • NDMO N/A
  • IPO Year
  • ARCT N/A
  • NDMO N/A
  • Fundamental
  • Price
  • ARCT $13.78
  • NDMO $10.20
  • Analyst Decision
  • ARCT Strong Buy
  • NDMO
  • Analyst Count
  • ARCT 8
  • NDMO 0
  • Target Price
  • ARCT $52.83
  • NDMO N/A
  • AVG Volume (30 Days)
  • ARCT 484.1K
  • NDMO 218.6K
  • Earning Date
  • ARCT 08-04-2025
  • NDMO 01-01-0001
  • Dividend Yield
  • ARCT N/A
  • NDMO 6.75%
  • EPS Growth
  • ARCT N/A
  • NDMO N/A
  • EPS
  • ARCT N/A
  • NDMO N/A
  • Revenue
  • ARCT $143,680,000.00
  • NDMO N/A
  • Revenue This Year
  • ARCT N/A
  • NDMO N/A
  • Revenue Next Year
  • ARCT $34.79
  • NDMO N/A
  • P/E Ratio
  • ARCT N/A
  • NDMO N/A
  • Revenue Growth
  • ARCT 15.38
  • NDMO N/A
  • 52 Week Low
  • ARCT $8.04
  • NDMO $8.99
  • 52 Week High
  • ARCT $25.88
  • NDMO $11.24
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 57.25
  • NDMO 60.07
  • Support Level
  • ARCT $12.65
  • NDMO $9.95
  • Resistance Level
  • ARCT $14.09
  • NDMO $10.04
  • Average True Range (ATR)
  • ARCT 0.93
  • NDMO 0.10
  • MACD
  • ARCT 0.05
  • NDMO 0.01
  • Stochastic Oscillator
  • ARCT 60.04
  • NDMO 75.76

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

Share on Social Networks: